Live Feed

– Independent, peer-reviewed, placebo-controlled trial conducted by Lund University showed pramipexole significantly reduced anhedonia (primary endpoint, Hedges' g=0.62, p=0.006) – – Benefit extended to independent anhedonia and apathy measures (DARS, AES-S) and was sustained through six months of open-label treatment – – Findings reinforce the dopaminergic mechanism underlying ALTO-207; potentially pivotal Phase 2b trial in treatment-resistant depression is ongoing with data expected in 2H 2027 – Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO) today highlighted the publication in Nature Medicine of PRIME-PRAXOL, an independent, randomized, double-blind, placebo-controlled trial of the d

The count of cities with $1 million starter homes has nearly tripled since 2020, an enduring sign of how the pandemic housing boom reset affordability for first-time buyersThe number of cities where a typical starter home is worth $1 million or more has nearly tripled since before the pandemic, rising from 80 in February 2020 to a record 242 today.California still has the most cities with million-dollar starter homes, but New York and New Jersey are seeing the fastest growth.Nationwide, the typical starter home is worth $198,649, up 1.7% from a year ago.SEATTLE, June 15, 2026 /PRNewswire/ -- The bar for entry-level homeownership has never been higher. While the typical starter home nationwid

Marking its 10th consecutive year at VivaTech, ManpowerGroup will unveil new workforce research, showcase AI-powered innovation, and share practical insights on how organizations can build the workforce readiness needed to turn AI ambition into business impact.MILWAUKEE, June 15, 2026 /PRNewswire/ -- ManpowerGroup, a global leader in workforce solutions, returns to VivaTech for the 10th consecutive year, bringing new workforce research, AI-powered innovations, and practical insights to one of the defining business challenges of the AI era: turning technology investment into business impact through people. Under the theme Human

DETROIT, June 15, 2026 /PRNewswire/ -- Dauch Corporation, (NYSE:DCH, LSE: DCH)), formerly American Axle & Manufacturing Holdings Inc., confirms today that its represented workforce, UAW Local 2093, at its Three Rivers Manufacturing Facility in Michigan, has ratified a new, four-year collective bargaining agreement.  Associates employed at the facility will return to their positions today, allowing for regular operations to resume.About DauchDauch Corporation is a premier Driveline and Metal Forming supplier serving the global automotive industry with a powertrain-agnostic product portfolio that supports electric, hybrid, and in

8-K - COMTECH TELECOMMUNICATIONS CORP /DE/ (0000023197) (Filer)

Collaboration is intended to support practical migration pathways to AMD EPYC processor-basedinfrastructure, with TD SYNNEX supporting EigenQ channel and public-sector go-to-market readinesswhere approved and applicable.COLUMBIA, Md., June 15, 2026 /PRNewswire/ -- EigenQ, Inc. today announced a collaboration with TD SYNNEX (NYSE:SNX) intended to help public-sector, defense, critical infrastructure and enterprise customers assess and prepare AMD EPYC™ processor-based server environments for the post-quantum security transition. As organizations plan for the migration from classical public-key cryptography to quantum-resistant ap

6-K - AXIA Energia S.A. (0001439124) (Filer)

8-K - Spyre Therapeutics, Inc. (0001636282) (Filer)

10-Q - COMTECH TELECOMMUNICATIONS CORP /DE/ (0000023197) (Filer)

8-K - AIM ImmunoTech Inc. (0000946644) (Filer)

8-K - Telomir Pharmaceuticals, Inc. (0001971532) (Filer)

8-K - ALPHA MODUS HOLDINGS, INC. (0001862463) (Filer)

Vancouver, British Columbia--(Newsfile Corp. - June 15, 2026) - Cosa Resources Corp. (TSXV:COSA) (OTCQB:COSAF) (FSE: SSKU) ("Cosa" or the "Company") is pleased to announce summer plans for the Company's Darby ("Darby") project. Darby is a joint venture (the "Joint Venture") between Cosa and Denison Mines Corp. (TSX:DML) (NYSE:DNN) ("Denison") and is located 10 kilometres west of Cameco's Cigar Lake Mine in the eastern Athabasca Basin, Saskatchewan (Figure 1). Cosa is the operator of Darby and holds a 70% interest with Denison holding a 30% interest. Drilling at Darby is expected after completion of a significant drill program at the Company's Murphy Lake North joint venture to follow up uran

~ Dominari Allocated 1,481,481 IPO shares of SpaceX NEW YORK, June 15, 2026 /PRNewswire/ -- Dominari Securities LLC, a wholly owned subsidiary of Dominari Holdings Inc. (NASDAQ:DOMH), is pleased to announce the successful launch and closing of the American Ventures Opportunity QP Series IV – SpaceX Fund, (hereinafter, the "Fund"). The Fund successfully raised approximately $200,000,000.00 from qualified investors and deployed that capital to directly acquire 1,481,481 IPO shares of SpaceX at a price of $135.00 per share in what the Wall Street Journal called the smoothest IPO in recent history, as well as the largest IPO ever.

8-K - Ramaco Resources, Inc. (0001687187) (Filer)

8-K - Rumble Inc. (0001830081) (Filer)

8-K - PDS Biotechnology Corp (0001472091) (Filer)

8-K - Functional Brands Inc. (0001837254) (Filer)

New dealer relationship expands access to Wabash trailers, truck bodies, parts and service to help fleets maximize uptime near one of Canada's most important freight corridors Wabash (NYSE:WNC), a leader in end-to-end supply chain solutions for the transportation, logistics and infrastructure markets, today announced a new partnership with Transport Trailer Sales Inc., a full-service trailer dealership headquartered in Milton, Ontario. The agreement expands Wabash's Canadian dealer network and increases customer access to trailers, truck bodies, parts and service across the Greater Toronto Area and Eastern Canada. Wabash continues to advance its dealer growth strategy by expanding relat

OCALA, Fla., June 15, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM," or the "Company"), an immuno-pharma company focused on the development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases, today announced that it has received written notice from the NYSE American that AIM has regained compliance with NYSE American's continued listing standards related to stockholders' equity. On May 7, 2026, the Company entered into a warrant exercise inducement offer letter agreement with certain a holder of existing warrants, pursuant to which the holders agreed to exercise their warrants in cash at a reduced exercise price for aggregate gross pr